(Q43767889)
Statements
1 reference
CYP2B6 and CYP2C19 as the major enzymes responsible for the metabolism of selegiline, a drug used in the treatment of Parkinson's disease, as revealed from experiments with recombinant enzymes (English)
1 reference
1 reference
M Hidestrand
1 reference
M Oscarson
1 reference
J S Salonen
1 reference
L Nyman
1 reference
O Pelkonen
1 reference
M Ingelman-Sundberg
1 reference
1 November 2001
1 reference
1 reference